SBI Securities’s VanEck Pharmaceutical ETF PPH Stock Holding History

SBI Securities’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.4K	Sell	287 -41	-13%	-$4.24K	﹤0.01%	1358
2026 Q1	$34.1K	Buy	328 +13	+4%	+$1.39K	﹤0.01%	1249
2025 Q4	$32.5K	Sell	315 -8	-2%	-$778	﹤0.01%	1258
2025 Q3	$29.2K	Buy	323 +39	+14%	+$3.42K	﹤0.01%	1308
2025 Q2	$25K	Sell	284 -55	-16%	-$4.77K	﹤0.01%	1323
2025 Q1	$30.9K	Buy	339 +7	+2%	+$630	﹤0.01%	1168
2024 Q4	$28.6K	Buy	+332	New	+$30K	﹤0.01%	1194

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

SBI Securities's PPH Position: Q2 2026 in Review

SBI Securities reduced its VanEck Pharmaceutical ETF (PPH) stake by 13% in Q2 2026, selling an estimated $4.24K and leaving 287 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

SBI Securities first reported a position in PPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $34.1K in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

SBI Securities held 287 shares of VanEck Pharmaceutical ETF worth $31.4K as of Q2 2026.
SBI Securities sold 41 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $4.24K.
VanEck Pharmaceutical ETF made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1358 holding.
SBI Securities first reported a position in VanEck Pharmaceutical ETF in Q4 2024 and has held it in 7 quarters since.
SBI Securities's VanEck Pharmaceutical ETF position peaked at $34.1K in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.